OIG Warns Providers Of Fraud Within Telemedicine Companies

OIG issued a special fraud alert on Wednesday (July 20) warning providers to exercise caution when entering agreements with telemedicine companies due to findings that some companies used the growing acceptance of telehealth to execute kickback schemes involving fraudulent orders for durable medical equipment, prescriptions and other tests. The report seemingly combines previously separate telehealth fraud and telefraud into a new type of fraud that is diverging from initial definitions as telehealth services continue to expand during the COVID-19 pandemic...
Article Type: 
Site Name: 
InsideHealthPolicy.com
Author: 
Topics: 

E&C Advances Privacy Bill Without Clarifying Abortion Implications

The American Data Privacy and Protection Act cleared the full House Energy & Commerce Committee Wednesday (July 20), a major step forward for the first-of-its-kind bipartisan privacy legislation, but lawmakers didn’t clarify whether the bill would protect pregnant people in states that outlaw abortion from having their data shared with law enforcement. Rep. Anna Eshoo (D-CA) said the current version of the legislation is flawed because it does not address the health app privacy concerns created by the high court’s...
Article Type: 
Site Name: 
InsideHealthPolicy.com
Author: 
Topics: 

E&C Advances Privacy Bill Without Clarifying Abortion Implications

The American Data Privacy and Protection Act cleared the full House Energy & Commerce Committee Wednesday (July 20), a major step forward for the first-of-its-kind bipartisan privacy legislation, but lawmakers didn’t clarify whether the bill would protect pregnant people in states that outlaw abortion from having their data shared with law enforcement. Rep. Anna Eshoo (D-CA) said the current version of the legislation is flawed because it does not address the health app privacy concerns created by the high court’s...
Article Type: 
Tags: 
Site Name: 
InsideHealthPolicy.com
FDA Issue: 
FDA Week - 07/22/2022
FDA Volume: 
Vol. 28, No. 29
Author: 




Covered CA Proposes Moderate Rate Hike, Again Calls For ARP Extension

Covered California insurers have proposed an average 6% rate hike for 2023, which is higher than in recent years but still lower than the 10% national average, Executive Director Jessica Altman announced Tuesday (July 19), referring to a Kaiser Family Foundation examination of filings in 13 states and DC. But Californians could pay much higher rates if Congress doesn’t extend the enhanced tax credits enacted under the American Rescue Plan that are set to expire in December, and lawmakers need...
Article Type: 
Site Name: 
InsideHealthPolicy.com
HEA Issue: 
Health Exchange Alert Weekly Report - 07/27/2022
HEA Volume: 
Vol. 10, No. 30
Author: 

At CMS’ Request, TennCare Plans To Abandon Closed Drug Formulary

At the request of CMS, Tennessee’s Medicaid officials are withdrawing plans to exclude some drugs from TennCare’s drug formulary as part of changes to the block-grant-like funding of its Medicaid program, according to a draft amendment to the state’s 1115 demonstration . CMS in June requested that TennCare remove the expenditure authority for operating a closed formulary and other pharmacy-related flexibilities that would allow the state to exclude certain high-cost drugs from coverage without losing the guarantee of at least...
Article Type: 
Site Name: 
InsideHealthPolicy.com
IDP Issue: 
Inside Drug Pricing - 07/25/2022
IDP Volume: 
Vol. 5, No. 30
Author: 
Topics: 

House Passes Fiscal 2023 Minibus That Gives FDA $341M Funding Hike

The House on Wednesday (July 20) passed by a vote of 220-207 a six-bill funding package that gives FDA $3.6 billion in discretionary funding for fiscal 2023, an increase of $341 million over fiscal 2022 levels. The legislative package comprises six of the 12 funding bills, including the FDA-agriculture bill; it does not include the HHS spending bill. The legislation offers an increase of $64 million for drug and device activities, including for FDA’s efforts to manage the opioid crisis,...
Article Type: 
Tags: 
Site Name: 
InsideHealthPolicy.com
FDA Issue: 
FDA Week - 07/22/2022
FDA Volume: 
Vol. 28, No. 29
Author: 




Pages

Log in to access this content.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.